GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Australian Clinical Labs falls 2.12% in Monday's session

Published by Global Banking & Finance Review

Posted on November 2, 2026

1 min read
Add as preferred source on Google
ACL.AX 3.23 -2.12% last traded price, 2 Nov 2026
Previous close
3.30
Market cap
—

Source: Eulerpool. The figures in this article were checked against this snapshot before publication.

Australian Clinical Labs on the Australian market saw its shares last traded 2.12% below their previous close at 3.23 AUD on 2 November 2026. The health care company’s shares moved lower compared with the previous close of 3.30 AUD.

Last traded price3.23 AUD
Previous close3.30 AUD
Change from the previous close-2.12%

Prices of Australian Clinical Labs (ACL.AX), listed in Australia, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 2 November 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 30 October 2026. We report a stock the day it ends a session 2% or more away from its previous close, where at least 100,000 shares traded in the previous session. Source: Eulerpool. How we compile these reports.

Australian Clinical Labs — daily ASX:ACL

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Australian Clinical Labs on TradingView ↗

Related Articles

More from Markets

Explore more articles in the Markets category